Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness

Biomedical Papers

Volumn 157, Issue 1, 2013, Pages 41-49

  Karasek, David ^a   Vaverkova, Helena ^a   Halenka, Milan ^a   Jackuliakova, Dagmar ^a   Frysak, Zdenek ^a   Orsag, Jiri ^a   Novotny, Dalibor ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Dyslipidemia; Hypertension; Insulin resistance; Intima media thickness; Prehypertension

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CZECH REPUBLIC; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOLOGY; PREHYPERTENSION; PREVALENCE; WAIST CIRCUMFERENCE;

ADULT; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; CZECH REPUBLIC; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREHYPERTENSION; PREVALENCE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84875776956     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2012.046     Document Type: Article

References (54)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
2. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with angiotensin-receptor blocker. N Engl J Med 2006;354:1685-97.
3. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
4. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005;36:1859-63.
5. Mainous AG 3rd, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 2004;94:1496-500.
6. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004;164:2113-8.
7. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006;47:410-4.
8. Cordero A, Laclaustra M, León M, Grima A, Casasnovas JA, Luengo E, del Rio A, Ferreira I, Alegria E. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens 2006;19:189-96.
9. Sniderman AD. Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm. Curr Opin Lipidol 2004;15:433-8.
10. de Graaf J, Couture P, Sniderman A. A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias. Nat Clin Pract Endocrinol Metab 2008;4:608-18.
11. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PW, Castelli WP, Schaefer EJ. LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb 1992;12:1410-9.
12. Demacker PN, Veerkamp MJ, Bredie SJ, Marcovina SM, de Graaf J, Stalenhoef AF. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 2000;153:483-90.
13. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:515-23.
14. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem 1997;43:2364-78.
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
16. National Cholesterol Education Program (U.S.) Risk assessment tool for estimating your 10-year risk of having a heart attack [electronic resource], available from: http://hp2010.nhlbihin.net/atpiii/calculator.asp.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
18. Karasek D, Vaverkova H, Frysak Z, Halenka M, Jackuliakova D, Novotny D, Lukes J. Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects. Int Angiol 2011;30:441-50.
19. Karasek D, Vaverkova H, Halenka M, Jackuliakova D, Frysak Z, Slavik L, Novotny D. Prothrombotic markers in asymptomatic dyslipidemic subjects. J Thromb Thrombolysis 2011;31:27-36.
20. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, Shyu YK. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005;23:1355-60.
21. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006;48:254-9.
22. Lee JH, Hwang SY, Kim EJ, Kim MJ. Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers. Public Health Nurs 2006;23:314-23.
23. Janghorbani M, Amini M, Gouya MM, Delavari A, Alikhani S, Mahdavi A. Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens 2008;26:419-26.
24. Zhang M, Batu B, Tong W, Li H, Lin Z, Li Y, Zhang X, Zhang Y. Prehypertension and cardiovascular risk factor clustering among Mongolian population in rural and animal husbandry area, Inner Mongolia, China. Circ J 2009;73:1437-41.
25. Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults. J Cardiovasc Pharmacol 2009;53:388-400.
26. Hageman PA, Pullen CH, Walker SN, Boeckner LS. Blood pressure, fitness, and lipid profiles of rural women in the wellness for women project. Cardiopulm Phys Ther J 2010;21:27-34.
27. Sit JW, Sijian L, Wong EM, Yanling Z, Ziping W, Jianqiang J, Yanling C, WongTK. Prevalence and risk factors associated with prehypertension: identification of foci for primary prevention of hypertension. J Cardiovasc Nurs 2010;25:461-9.
28. Ferguson TS, Younger N, Tulloch-Reid MK, Forrester TE, Cooper RS, Van den Broeck J, Wilks RJ. Prevalence of the metabolic syndrome in Jamaican adults and its relationship to income and education levels. West Indian Med J 2010;59:265-73.
29. Isezuo SA, Sabir AA, Ohwovorilole AE, Fasanmade OA. Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens 2011;25:224-30.
30. Nery AB, Mesquita ET, Lugon JR, Kang HC, de Miranda VA, de Souza BG, AndradeJA, Rosa ML. Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme. Eur J Cardiovasc Prev Rehabil 2011;18:233-9.
31. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension 2006;47:45-50.
32. Laaksonen DE, Niskanen L, Nyyssönen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J 2008;29:2561-8.
33. Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women. J Hum Hypertens 2011; doi:10.1038/jhh.2011.70. [Epub ahead of print].
34. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139:761-76.
35. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006;116:607-14.
36. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-62.
37. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989;1:974-82.
38. Knobler H, Abbasi F, Lamendola C, Reaven GM. Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension. Diab Vasc Dis Res 2011;8:43-6.
39. Hwu CM, Liou TL, Hsiao LC, Lin MW. Prehypertension is associated with insulin resistance. QJM 2009;102:705-11.
40. Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens (Greenwich) 2011;13:238-43.
41. Skøtt P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck Nielsen H, Parving HH. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989;32:694-9.
42. Endre T, Mattiasson I, Berglund G, Hulthén UL. Insulin and renal sodium retention in hypertension-prone men. Hypertension 1994;23:313-9.
43. Rooney DP, Edgar JD, Sheridan B, Atkinson AB, Bell PM. The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest 1991;21:430-5.
44. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
45. Kern W, Fittje A, Fohr W, Kerner W, Born J, Fehm HL. Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects. Exp Clin Endocrinol Diabetes 2000;108:498-505.
46. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension 2004;43:1324-31.
47. Hwu CM, Liou TL, Hsiao LC, Lin MW. Prehypertension is associated with insulin resistance. QJM 2009;102:705-11.
48. Lai TS, Curhan GC, Forman JP. Insulin resistance and risk of incident hypertension among men. J Clin Hypertens (Greenwich) 2009;11:483-90.
49. Panagiotakos DB, Chrysohoou C, Pitsavos C, Skoumas J, Lentzas Y, Katinioti A, Stefanadis C. Hierarchical analysis of anthropometric indices in the prediction of 5-year incidence of hypertension in apparently healthy adults: the ATTICA study. Atherosclerosis 2009;206:314-20.
50. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, Howard BV, Devereux RB. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009;54:974-80.
51. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001;29:72-5.
52. Manios E, Tsivgoulis G, Koroboki E, Stamatelopoulos K, Papamichael C, Toumanidis S, Stamboulis E, Vemmos K, Zakopoulos N. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass. Stroke 2009;40:1515-8.
53. Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JS, Hartiala JJ, Raitakari OT. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000;36:929-33.
54. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, DeBacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.